{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:49:15Z","timestamp":1792842555684,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001641","name":"Glaucoma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["14111816"],"award-info":[{"award-number":["14111816"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","award":["4054302"],"award-info":[{"award-number":["4054302"]}],"id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.phymed.2021.153595","type":"journal-article","created":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T09:57:26Z","timestamp":1621159046000},"page":"153595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Characterization of liver injury induced by a pyrrolizidine alkaloid in rats"],"prefix":"10.1016","volume":"89","author":[{"given":"Xinmeng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9686-2817","authenticated-orcid":false,"given":"Jiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2217-6758","authenticated-orcid":false,"given":"Yisheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8015-2674","authenticated-orcid":false,"given":"Qihe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2021.153595_bib0001","first-page":"252","article-title":"Hepatic veno-occlusive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations","volume":"68","author":"Chen","year":"2010","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.phymed.2021.153595_bib0002","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.1840200213","article-title":"A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies","volume":"20","author":"Chevallier","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2021.153595_bib0003","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.3748\/wjg.v13.i10.1628","article-title":"Gynura root induces hepatic veno-occlusive disease: a case report and review of the literature","volume":"13","author":"Dai","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phymed.2021.153595_bib0004","doi-asserted-by":"crossref","first-page":"G1045","DOI":"10.1152\/ajpgi.00526.2002","article-title":"Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome","volume":"284","author":"DeLeve","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.phymed.2021.153595_bib0005","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.510290615","article-title":"Characterization of a reproducible rat model of hepatic veno-occlusive disease","volume":"29","author":"DeLeve","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2021.153595_bib0006","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0016-5085(03)01056-4","article-title":"Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition","volume":"125","author":"Deleve","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phymed.2021.153595_bib0007","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.matbio.2015.01.004","article-title":"Matrix metalloproteinases in liver injury, repair and fibrosis","volume":"44-46","author":"Duarte","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.phymed.2021.153595_bib0008","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.fct.2018.03.005","article-title":"Risk assessment of pyrrolizidine alkaloids in food of plant and animal origin","volume":"115","author":"Dusemund","year":"2018","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.phymed.2021.153595_bib0009","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/19440049.2010.547520","article-title":"Pyrrolizidine alkaloids in food: a spectrum of potential health consequences","volume":"28","author":"Edgar","year":"2011","journal-title":"Food Addit. Contam. Part A"},{"key":"10.1016\/j.phymed.2021.153595_bib0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jceh.2014.10.002","article-title":"Sinusoidal obstruction syndrome (hepatic veno-occlusive disease)","volume":"4","author":"Fan","year":"2014","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.phymed.2021.153595_bib0011","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(01)00020-4","article-title":"Senecio disease, or cirrhosis of the liver due to senecio poisoning","volume":"196","author":"Willmot","year":"1920","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2021.153595_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DMR-120028426","article-title":"Pyrrolizidine alkaloids - Genotoxicity, metabolism enzymes, metabolic activation, and mechanisms","volume":"36","author":"Fu","year":"2004","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.phymed.2021.153595_bib0013","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1751-2980.2011.00552.x","article-title":"Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids","volume":"13","author":"Gao","year":"2012","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.phymed.2021.153595_bib0014","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.2147\/DDDT.S87858","article-title":"Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome","volume":"9","author":"Gao","year":"2015","journal-title":"Drug Des. Dev. Ther"},{"key":"10.1016\/j.phymed.2021.153595_bib0015","doi-asserted-by":"crossref","first-page":"L363","DOI":"10.1152\/ajplung.00212.2011","article-title":"The monocrotaline model of pulmonary hypertension in perspective","volume":"302","author":"Gomez-Arroyo","year":"2012","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.phymed.2021.153595_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31723","article-title":"Mutational signature analysis reveals widespread contribution of pyrrolizidine alkaloid exposure to human liver cancer","author":"He","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2021.153595_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2020.115542","article-title":"Comprehensive investigation and risk study on pyrrolizidine alkaloid contamination in Chinese retail honey","volume":"267","author":"He","year":"2020","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.phymed.2021.153595_bib0018","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2036.2006.02742.x","article-title":"Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome","volume":"23","author":"Helmy","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2021.153595_bib0019","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","article-title":"Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies","volume":"46","author":"Hemmann","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2021.153595_bib0020","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The myofibroblast - One function, multiple origins","volume":"170","author":"Hinz","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phymed.2021.153595_bib0021","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0163-7258(90)90063-8","article-title":"Activation and pulmonary toxicity of pyrrolizidine alkaloids","volume":"47","author":"Huxtable","year":"1990","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2021.153595_bib0022","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.2005.088690","article-title":"Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis","volume":"56","author":"Inagaki","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.phymed.2021.153595_bib0023","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-2697(81)90261-X","article-title":"A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues","volume":"112","author":"Jamall","year":"1981","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.phymed.2021.153595_bib0024","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/j.gastro.2009.09.015","article-title":"Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition","volume":"138","author":"Kluwe","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phymed.2021.153595_bib0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0168-8278(00)00037-4","article-title":"Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C","volume":"34","author":"Lichtinghagen","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2021.153595_bib0026","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2010.07.031","article-title":"Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum","volume":"54","author":"Lin","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2021.153595_bib0027","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12876-020-1180-0","article-title":"Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.phymed.2021.153595_bib0028","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1007\/s00204-018-2309-6","article-title":"The role of formation of pyrrole-ATP synthase subunit beta adduct in pyrrolizidine alkaloid-induced hepatotoxicity","volume":"92","author":"Lu","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.phymed.2021.153595_bib0029","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1021\/acs.chemrestox.8b00369","article-title":"Pyrrole-hemoglobin adducts, a more feasible potential biomarker of pyrrolizidine alkaloid exposure","volume":"32","author":"Ma","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.phymed.2021.153595_bib0030","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jfda.2018.05.005","article-title":"Pyrrole-protein adducts - A biomarker of pyrrolizidine alkaloid-induced hepatotoxicity","volume":"26","author":"Ma","year":"2018","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.phymed.2021.153595_bib0031","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00204-020-02947-4","article-title":"Clinical application of pyrrole-hemoglobin adducts as a biomarker of pyrrolizidine alkaloid exposure in humans","volume":"95","author":"Ma","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.phymed.2021.153595_bib0032","first-page":"L790","article-title":"TGF-beta 1 stimulates human AT(1) receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways","volume":"293","author":"Martin","year":"2007","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.phymed.2021.153595_bib0033","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0140-6736(76)90726-1","article-title":"An outbreak of hepatic veno-occlusive disease in north-western Afghanistan","volume":"2","author":"Mohabbat","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2021.153595_bib0034","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/gutjnl-2012-302274","article-title":"A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity","volume":"62","author":"Oancea","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.phymed.2021.153595_bib0035","doi-asserted-by":"crossref","first-page":"892","DOI":"10.2527\/1990.683892x","article-title":"Natural plant toxicants in milk - a review","volume":"68","author":"Panter","year":"1990","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.phymed.2021.153595_bib0036","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0168-8278(97)80359-5","article-title":"TIMP expression in toxic and cholestatic liver injury in rat","volume":"27","author":"Roeb","year":"1997","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2021.153595_bib0037","first-page":"711","article-title":"Medicinal plants in China containing pyrrolizidine alkaloids","volume":"55","author":"Roeder","year":"2000","journal-title":"Pharmazie"},{"key":"10.1016\/j.phymed.2021.153595_bib0038","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/tx500071q","article-title":"Metabolic activation of pyrrolizidine alkaloids: insights into the structural and enzymatic basis","volume":"27","author":"Ruan","year":"2014","journal-title":"Chem. Res. Toxicol"},{"key":"10.1016\/j.phymed.2021.153595_bib0039","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s00204-019-02499-2","article-title":"Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids","volume":"93","author":"Yang","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.phymed.2021.153595_bib0040","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41401-018-0155-y","article-title":"Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors","volume":"40","author":"Zhang","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2021.153595_bib0041","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.foodcont.2017.10.026","article-title":"Contamination of hepatotoxic pyrrolizidine alkaloids in retail honey in China","volume":"85","author":"Zhu","year":"2018","journal-title":"Food Control"},{"key":"10.1016\/j.phymed.2021.153595_bib0042","article-title":"Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China","author":"Zhu","year":"2020","journal-title":"Acta Pharmacol. Sin"},{"key":"10.1016\/j.phymed.2021.153595_bib0043","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1111\/liv.13684","article-title":"Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease","volume":"38","author":"Zhuge","year":"2018","journal-title":"Liver. Int."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321001379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321001379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:28:00Z","timestamp":1760552880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711321001379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":43,"alternative-id":["S0944711321001379"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153595","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of liver injury induced by a pyrrolizidine alkaloid in rats","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153595"}}